Search - tctmd.com

Displaying 61 - 80 of 115

Sort: Relevancy | Date

Presentation TCT 2019

Moving From “Signal Detection” to “Signal Discernment”: An FDA View

Presenter: Eleni Whatley

September 26, 2019

Presentation TVT 2019

TENDYNE: Attributes, Challenges, and Clinical Data (SUMMIT)

Presenter: Gorav Ailawadi

June 14, 2019

Presentation TVT 2019

INTREPID: Attributes, Challenges, and Clinical Data (APOLLO)

Presenter: Martin Leon

June 14, 2019

Presentation TVT 2019

Reactions From the Surgical Community

Presenter: Patrick McCarthy

June 13, 2019

Presentation TVT 2019

Reactions From the Cardiology Community

Presenter: Blase Carabello

June 13, 2019

Presentation TVT 2019

Highlights From the CoreValve Low-Risk Trial

Presenter: Jeffrey Popma

June 13, 2019

Presentation TVT 2019

Highlights From the PARTNER 3 Low-Risk Trial

Presenter: Michael Mack

June 13, 2019

Presentation CIT 2019

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Presenter: Yaling Han

March 28, 2019

Presentation ACC 2019

Results from the PANACHE Phase 2b RCT

Presenter: Sanjiv J. Shah

March 17, 2019

Presentation TCT 2018

Updated RCT Data for PFO Closure in All-Comers and Subgroups With Cryptogenic Stroke: How Should the Guidelines Be Updated?

Presenter: Teiji Akagi, John D. Carroll, Konstantinos Dean Boudoulas

September 22, 2018

Presentation TCT 2018

EffPac-RCT: A Randomized Trial Evaluating a Drug-Coated Balloon in Superficial Femoral and Popliteal Arteries

Presenter: Lindsay S. Machan, Craig M. Walker, Marcus Thieme

September 22, 2018

Presentation The Structural Heart Disease Summit 2018

The TENDYNE Program: Attributes, Challenges, and Clinical Data (FDA Pivotal RCT)

Presenter: Rashmi Yadav

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The INTREPID Program: Attributes, Challenges, and Clinical Data (FDA Pivotal RCT APOLLO)

Presenter: Vinayak Bapat

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Neochord Forges Ahead: Technology and Clinical Updates (FDA Pivotal RCT)

Presenter: Andrea Colli

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Carillon Rejuvenated: Technology and Clinical Updates (FDA Pivotal RCT)

Presenter: Tessel N Vossenberg

June 21, 2018

Presentation TCT 2017

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Presenter: Azeem Latib, Dean J. Kereiakes

October 31, 2017

Presentation TCT 2017

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

Presenter: Azeem Latib, Bernard R. Chevalier

October 31, 2017

Presentation TCT 2017

ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings

Presenter: Azeem Latib, Manel Sabate

October 31, 2017

Advertisement

Moving From “Signal Detection” to “Signal Discernment”: An FDA View

TENDYNE: Attributes, Challenges, and Clinical Data (SUMMIT)

INTREPID: Attributes, Challenges, and Clinical Data (APOLLO)

Reactions From the Surgical Community

Reactions From the Cardiology Community

Highlights From the CoreValve Low-Risk Trial

Highlights From the PARTNER 3 Low-Risk Trial

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Results from the PANACHE Phase 2b RCT

Updated RCT Data for PFO Closure in All-Comers and Subgroups With Cryptogenic Stroke: How Should the Guidelines Be Updated?

EffPac-RCT: A Randomized Trial Evaluating a Drug-Coated Balloon in Superficial Femoral and Popliteal Arteries

The TENDYNE Program: Attributes, Challenges, and Clinical Data (FDA Pivotal RCT)

The INTREPID Program: Attributes, Challenges, and Clinical Data (FDA Pivotal RCT APOLLO)

Neochord Forges Ahead: Technology and Clinical Updates (FDA Pivotal RCT)

Carillon Rejuvenated: Technology and Clinical Updates (FDA Pivotal RCT)

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content